Update on BEO 001 Clinical Proof-of-Concept Study

11:30 am - Thursday 29th January 2026

  • Ongoing clinical trial in 99 patients to evaluate BEO 001 efficacy and safety
  • Predictive response model predicting clinical efficacy

Speakers:

Rikke C Nielsen
CEO
BEO Therapeutics